BioSpace News Archive

Business

Wave Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced financial results for the fourth quarter and full year ended December 31, 2021 and provided a business update.

March 3, 2022
·
17 min read
Pharm Country

Provention Bio to Present at Two Upcoming Virtual Investor Conferences in March 2022

Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, announced that management will participate in two upcoming virtual investor conferences in March.

March 3, 2022
·
2 min read
Business

GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2021

GlycoMimetics, Inc. (Nasdaq: GLYC) today reported its financial results and highlights for the fourth quarter and year ended December 31, 2021. Cash and cash equivalents at December 31, 2021 were $90.3 million.

March 3, 2022
·
11 min read
Recursion Provides Updated Guidance on Clinical Trial Starts

Recursion (NASDAQ: RXRX) today provided updated guidance on clinical trial starts.

March 3, 2022
·
4 min read
Pharm Country

Petros Pharmaceuticals to Present at the Q1 Investor Summit Conference

Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Q1 Investor Summit Conference, which is being held virtually on March 8 – 9, 2022.

March 3, 2022
·
1 min read
Business

Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2021 Financial Results and Provide Business Update

Selecta Biosciences, Inc. today announced that it plans to host a conference call on Thursday, March 10, 2021, at 8:30 a.m. ET to discuss its financial results for the quarter and full-year ended December 31, 2021 and provide a business update.

March 3, 2022
·
1 min read
Business

AiM Medical Robotics Appoints Dr. Jonathan M. Sackier as Chief Medical Officer

AiM Medical Robotics, a leading developer of MRI-compatible intraoperative robotics for neurosurgery, today announced that Jonathan M. Sackier, MB, ChB, FRCS, FACS, DSc (Honoris causa). has been appointed as its Chief Medical Officer (CMO).

March 3, 2022
·
3 min read
Genetown

Yield10 Bioscience Announces an Update on the Camelina Line E3902 Development Program for Producing Low-carbon Feedstock Oil for Renewable Diesel

Yield10 Bioscience, Inc. announced an update on its Camelina line E3902 development program for the purpose of producing low-carbon feedstock oil for the renewable diesel market in the U.S. and Canada.

March 3, 2022
·
7 min read
Business

Entos Pharmaceuticals Announces Senior Leadership Appointments to Expand Executive Team and Accelerate Growth

Entos Pharmaceuticals today announced two executive-level appointments, Dr. Steve Chen as Chief Medical Officer.

March 3, 2022
·
3 min read
Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Inc. today announced that management will participate in upcoming investor conferences during March.

March 3, 2022
·
2 min read